Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 0.61 |
| ▸ | EPHX2 | P34913 | 7/20 | 0.58 |
| ▸ | NAAA | Q02083 | 1/20 | 0.58 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.51 |
| ▸ | FAAH | O00519 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | CNR1 | P21554 | 2/20 | 0.49 |
| ▸ | CNR2 | P34972 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9518772 | 0.94 | CASP2 (0.68) | CASP2EPHX2NAAAHPGDMEN1 | |
| SCHEMBL9518701 | 0.93 | CASP2 (0.71) | CASP2EPHX2NAAAFAAH | |
| SCHEMBL1146790 | 0.93 | CASP2 (0.71) | CASP2EPHX2NAAAFAAH | |
| SCHEMBL9502450 | 0.93 | CASP2 (0.71) | CASP2EPHX2NAAAFAAH | |
| SCHEMBL2616429 | 0.89 | CASP2 (0.67) | CASP2EPHX2NAAASLC6A5FAAH | |
| SCHEMBL12523062 | 0.89 | CASP2 (0.59) | CASP2EPHX2NAAAHPGDMEN1 | |
| SCHEMBL23253069 | 0.88 | CASP2 (0.56) | CASP2EPHX2NAAAPLA2G2AHPGD | |
| SCHEMBL25922800 | 0.88 | CASP2 (0.65) | CASP2EPHX2NAAASLC6A5FAAH | |
| SCHEMBL23394708 | 0.86 | CASP2 (0.62) | CASP2EPHX2NAAASLC6A5FAAH | |
| SCHEMBL12192205 | 0.86 | CASP2 (0.62) | CASP2EPHX2NAAASLC6A5FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3808760-A1 | COMPOUND COMPRISING SUBSTANCE HAVING AFFINITY FOR ANTIBODY, CLEAVAGE SITE AND REACTIVE GROUP, OR SALT THEREOF | AJINOMOTO CO., INC. (JP) | 2021-04-21 | — | — | EP | disclosed |
| EP-3617235-A1 | COMPOUND HAVING SUBSTANCE THAT HAS AFFINITY FOR SOLUBLE PROTEIN, CLEAVABLE MOIETY, AND REACTIVE GROUP, OR SALT THEREOF | Ajinomoto Co., Inc. (JP) | 2020-03-04 | — | — | EP | disclosed |